ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,157.09
0.57%
Dow Jones
38,739.46
0.16%
US Dollar vs MXN
16.91153
-0.42%
Brent Oil
83.275
0.18%
Bitcoin
63,299.85
-1.07%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cpex Pharmaceuticals, Inc. (MM) (CPEX)

  7. Cpex Pharmaceuticals, Inc. (MM) (CPEX) Noticias

CPEX

Cpex Pharmaceuticals, Inc. (MM) (CPEX)

Cpex Pharmaceuticals, Inc. (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CPEX
FechaHoraFuenteTítuloSímboloCompañía
07/04/201114:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
05/04/201115:53Edgar (US Regulatory)(25-NSE)NASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
05/04/201115:52Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
05/04/201115:39Business WireCPEX Completes Sale to FCB I HoldingsNASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
05/04/201114:59Edgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)NASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
05/04/201113:46Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
05/04/201112:53PR Newswire (US)Footstar Completes Acquisition of CPEX Pharmaceuticals, Inc.NASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
31/03/201109:54Edgar (US Regulatory)Annual Report (10-K)NASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
24/03/201108:21Business WireCPEX Stockholders Approve $27.25 Per Share Merger Agreement with FCB I HoldingsNASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
23/03/201114:00Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
23/03/201106:00Business WireCPEX Urges Stockholders to Consider the Facts of the Certain All-Cash FCB TransactionNASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
23/03/201105:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
22/03/201107:30PR Newswire (US)Mangrove Partners Notes CPEX Stock Trading Above Offer PriceNASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
21/03/201110:56Business WireCPEX Advises Stockholders to Vote Today for the All-Cash, Premium FCB TransactionNASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
21/03/201107:30PR Newswire (US)Mangrove Partners Expresses Disappointment in Board of CPEX Pharmaceuticals, Inc. and Reaffirms Proposed Recapitalization and InNASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
18/03/201108:36Business WireCPEX Pharmaceuticals Affirms Recommendation That Stockholders Vote for Merger Agreement With FCBNASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
17/03/201108:19Business WireCPEX Pharmaceuticals Advises Stockholders to Take No Action at This Time in Response to Mangrove Partners’ Revised ProposalNASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
17/03/201107:53Business WireCPEX Pharmaceuticals Continues to Recommend That Stockholders Vote for the Merger Agreement with FCBNASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
15/03/201107:30Business WireCPEX Pharmaceuticals Advises Stockholders to Take No Action at This Time in Response to Mangrove Partners’ ProposalNASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
14/03/201107:30PR Newswire (US)Mangrove Partners Proposes Fully-Financed Dividend Recapitalization to Board of CPEX Pharmaceuticals, Inc.NASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
11/03/201107:30Business WireISS Proxy Advisory Services Recommends That CPEX Stockholders Vote for Merger Agreement with FCB I HoldingsNASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
04/03/201111:27Business WireCPEX Receives Letter from Athyrium Capital ManagementNASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
04/03/201106:30PR Newswire (US)Mangrove Partners Responds to Erroneous CPEX AssertionsNASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
02/03/201114:00Business WireCPEX Sends Letter to StockholdersNASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
28/02/201106:30PR Newswire (US)Mangrove Partners Questions the Proposed Sale of CPEX Pharmaceuticals and Intends to Vote 'No' on the MergerNASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
28/02/201105:29Edgar (US Regulatory)Notice of exempt solicitation. Definitive material. (PX14A6G)NASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
24/02/201114:57Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
17/02/201106:34Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-A12B/A)NASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
14/02/201117:53Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
04/02/201107:31Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)NASDAQ:CPEXCpex Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:CPEX

Su Consulta Reciente

NYSE
XOM
Exxon Mobil
NASDAQ
AMZN
Amazon.com
FX
EURMXN
Euro vs MXN
NASDAQ
TSLA
Tesla
FX
USDMXN
US Dollar vs MXN
CCOM
OILBRENT
Brent Oil
PM
XAUUSD
Gold vs US Dollar
COIN
BTCUSD
Bitcoin
NYSE
CVX
Chevron
AMEX
SPY
SPDR S&P 500
USOTC
BNPQY
BNP Paribas (QX)
NYSE
BAC
Bank of America
NYSE
JPM
JP Morgan Chase
NASDAQ
MSFT
Microsoft
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados